- Home
- LODE vs WHWK Comparison
LODE vs WHWK Comparison
Compare LODE & WHWK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | LODE | WHWK |
|---|---|---|
| Founded | 2008 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Chemicals | Biotechnology: Pharmaceutical Preparations |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 174.8M | 95.2M |
| IPO Year | N/A | N/A |
Fundamental Metrics
Financial Performance| Metric | LODE | WHWK |
|---|---|---|
| Price | $3.28 | $2.38 |
| Analyst Decision | Hold | |
| Analyst Count | 1 | 0 |
| Target Price | ★ $4.00 | N/A |
| AVG Volume (30 Days) | ★ 818.6K | 186.0K |
| Earning Date | 10-30-2025 | 11-06-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | $2,778,445.00 | ★ $14,384,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1,798.62 | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 48.99 | N/A |
| 52 Week Low | $1.67 | $1.39 |
| 52 Week High | $10.10 | $3.81 |
Technical Indicators
Market Signals| Indicator | LODE | WHWK |
|---|---|---|
| Relative Strength Index (RSI) | 48.61 | 50.30 |
| Support Level | $3.13 | $2.10 |
| Resistance Level | $3.75 | $2.63 |
| Average True Range (ATR) | 0.23 | 0.17 |
| MACD | -0.02 | 0.02 |
| Stochastic Oscillator | 31.69 | 41.51 |
Price Performance
Historical ComparisonAbout LODE Comstock Inc.
Comstock Inc innovates and commercializes technologies that are deployable across entire industries to contribute to energy abundance by efficiently extracting and converting under-utilized natural resources, such as waste and other forms of woody biomass into renewable fuels, and end-of-life electronics into recovered electrification metals. Comstock's innovations group is engaged in developing and using artificial intelligence technologies for advanced materials development.
About WHWK Whitehawk Therapeutics Inc.
Whitehawk Therapeutics Inc is a preclinical stage oncology therapeutics. The company is engaged in applying technologies to established tumor biology to efficiently deliver improved cancer treatments. The company's three-asset ADC portfolio is engineered to overcome the limitations of first-generation predecessors to deliver a meaningful impact for patients with difficult-to-treat cancers.